EAAI Journal 2026 Journal Article
Inferring directed gene regulatory networks from single-cell ribonucleic acid sequencing data via multi-view contrastive learning
- Yangyang Meng
- Minhao Yao
- Tong Han
- Huandong Zhao
- Zhonghua Liu
- Baoshan Ma
Gene regulatory networks (GRNs) play a crucial role in understanding the structure and dynamics of cellular systems, revealing complex regulatory relationships, and exploring disease mechanisms. Recently, deep learning-based approaches have been proposed to infer GRNs from single-cell transcriptomics data with impressive results. However, these methods do not fully and dynamically adjust the relative importance and high-level features of the node embedding representations of graph models. In addition, GRNs of real species are large-scale networks with directionality and high sparsity, which hinders the advancement of GRN inference. To overcome these limitations, we propose a novel model based on multi-view contrastive learning (MCLGAT) to infer GRNs. MCLGAT is primarily an integration of graph attention network (GAT), multi-view frameworks, and contrastive learning fusion model. We used an adjacency matrix of GRN to generate a direction vector, therefore, MCLGAT can obtain directed gene regulation relationship. Improved GATs optimize attention weights and the multi-view models simultaneously extract the local feature and high-level feature of the nodes in the GRN. The contrastive learning fusion model dynamically adjusts the relative importance and effectively aggregates node embedding representations from both views. In comparisons with 10 state-of-the-art methods, MCLGAT achieved competitive performance on seven benchmark single-cell ribonucleic acid sequencing (scRNA-seq) datasets from four cell lines. Furthermore, potential biomarkers and therapeutic drugs for lung and breast cancer were identified using the candidate regulatory genes inferred by MCLGAT, which provides a theoretical basis for elucidating the gene regulatory mechanism of complex diseases and developing personalized diagnosis and treatment plans.